David F Skanchy is a Fort Worth, Texas based male Ophthalmologist who is specialized in Ophthalmology. Active license number of David F Skanchy is U9086 in Texas. David F Skanchy is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
David F Skanchy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
321 S Henderson St, Fort Worth, Texas, 76104-1016
Phone:
817-529-9949
Fax:
817-529-9943
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649831462
NPI Enumeration Date:
24 Jun, 2019
NPI Last Update On:
12 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David F Skanchy are as mentioned below.
License Number
Specialization
State
Status
U9086
Texas
Primary
4301508741
Ophthalmology
Michigan
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
321 S Henderson St, Fort Worth, Texas
Zip:
76104-1016
Phone Number:
817-529-9949
Fax Number:
817-529-9943
Patients can reach David F Skanchy at 321 S Henderson St, Fort Worth, Texas or can call to book an appointment on 817-529-9949. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.